Praktické lékárenství, 2015, issue 6

Editorial

Česká farmacie a Česká farmaceutická společnost ČLS JEP, z. s., v roce 2015

prof. PharmDr. Martin Doležal, Ph.D.

Prakt. lékáren. 2015; 11(6)  

Current pharmacotherapy

Targeted therapy in treatment of solid tumors

Lenka Doležalová

Prakt. lékáren. 2015; 11(6): 194-196  

In cancer treatment a number of procedures is applied, which are often combined. A surgical removal of the tumor along with part of the surrounding tissue is a radical solution. Tumors with the sensitivity to radiation are irradiated with ionizing radiation. The pharmacotherapy of cancer diseases includes conventional chemotherapy (cytostatics), hormone therapy, targeted therapy and anti-tumor immunotherapy. The course of treatment and drug selection are always based on tumor type, stage of disease and the patient’s clinical status. This article is focused on targeted drugs that have been used in clinical praxis of solid tumors „recently&...

A pharmacologically induced delirium

Richard Krombholz

Prakt. lékáren. 2015; 11(6): 198-202  

The side effects of the drugs for the brain and their potential to cause delirium. A pharmacologically induced delirium may represent a serious complication of the treatment of the primarilly non-psychiatric diseases. A number of drugs are known to have the ability to secondararily induced delirium within their side effects. The author in the following article highlights the main group of pharmaceuticals that have potential to cause delirium. With these problems are encountered especially the psychiatrists who are engaged in consulting services, as well as other colleagues caring for the psychiatric patients with somatic co- -morbidity. In...

Clinical pharmacy

Pharmaceutical care of selected diseases of the cardiovascular system in the elderly II.

Stanislava Kalafutová, Božena Jurašková, Josef Malý, Jiří Vlček

Prakt. lékáren. 2015; 11(6): 203-207  

The present article is a second part of the text focused on the pharmaceutical care of selected diseases of the cardiovascular system in the elderly I. This part has focused on pharmaceutical care in peripheral arterial disease, coronary heart disease and chronic heart failure, which are extended in the older population. In the health care of older patients with cardiovascular disease, in addition to pharmacological therapy equally important non-pharmacological interventions. The most important risk factors that can affect the rational provision of patient care in pharmacy include smoking, hyperlipoproteinemia and obesity and reduced physical...

Phytotherapy

Stevia rebaudiana - natural non-caloric sweetener

Zdeňka Navrátilová

Prakt. lékáren. 2015; 11(6): 217-218  

Stevia rebaudiana is a perennial herb native to South America (Paraguay). South-American Indians have since time immemorial used stevia as a sweetener and in traditional medicine. Developed countries have high rates of obesity and diabetes, so low-calorie sweeteners attract much interest. Stevia extract and compounds isolated from it have been used for decades in some Asian countries. In the European Union, its use in the food industry was permitted in 2011, and since then it has gained considerable popularity. Besides its zero calorie content, Stevia also exhibits anti-diabetic properties, so its use by diabetics is particularly advisable.

Hospital pharmacy

New advances in parenteral nutrition

Michal Janů

Prakt. lékáren. 2015; 11(6): 213-216  

The article introduces the key innovations in the field of parenteral nutrition. The first part describes new approaches in the clinical practice, particularly new recommendations for the intake of macronutrients and micronutrients. Next, a basic overview is presented of the current modern instrumentation necessary for safe and comfortable preparation of parenteral nutrition in pharmacies. Finally, a new method of administration is mentioned – mobile parenteral nutrition.

Information

Onemocnění z nachlazení

Jana Jurušová

Prakt. lékáren. 2015; 11(6): 208  

Self-treatment

Farmaceutical care for patients with hair loss

Jana Martinásková

Prakt. lékáren. 2015; 11(6): 219-221  

Pharmacies are often the first heath care facility, where patients complain about increased hair loss. There should be provided a qualified patient counselling on OTC products for the local and total additive therapy. Pharmacist or his assistant should manage to distinguish whether the patient’s problems can be handled by self-treatment or the patient should be sent to the doctor. This article briefly describes the types of alopecia and their possible causes. In detail occupies with effective agents for hair loss treatment and their characteristics. Listed is a practical summ ary of the free available products for the treatment of hair loss.

Case reports from the pharmaceutical practice

Hyperuricemia in patient allergic to allopurinol solved by a clinical pharmacist

Jitka Rychlíčková

Prakt. lékáren. 2015; 11(6): 210-212  

This case report presents a patient with hyperuricemia and gouty tophi on her hands. This patient is also allergic to usual urate-lowering therapy. Clinical pharmacist’s interventions (hydration, forced diuresis, support of glomerular filtration rate) are discussed. More options of urate-lowering therapy, other than allopurinol and febuxostat, are described.

Quiz

Autodidaktický test 6/2015

Prakt. lékáren. 2015; 11(6): 222-223  


Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.